Talian Hotline Kami
+603 - 8230 0300
Utama
Pengenalan
Latar Belakang
Visi, Misi & Nilai Teras
Objektif
Carta Organisasi
Kod Etika dan Tatakelakuan
Board of Directors
Top Management Team of MDA
Malaysian Leadership
Former CEO of MDA
Bahagian
Pejabat Ketua Eksekutif
Unit Komunikasi Korporat
Unit Undang-undang
Unit Integriti
Secretarial Unit
Bahagian Pendaftaran, Pelesenan Dan Penguatkuasaan
Post Market & Enforcement Division
Policy & Strategic Planning Division
International and Industry Affairs Division
Unit Pengurusan Dan Perkhidmatan
Soalan Lazim
Single License Policy Implementation
Pendaftaran, Pelesenan & Penguatkuasaan
Labelling of Medical Devices
Technical Evaluation
Hubungi
Borang Aduan Pelanggan
Direktori Kakitangan
Dokumen
Perundangan
Surat Pekeliling
Dokumen Panduan
Garis panduan
Standard
General Directions
Strategic Plan
Persembahan Slide
Infographic
Organizational Anti Corruption Plan (OACP) MDA 2022 - 2026
Buletin MDA
Press Release
Media Coverage (Newspaper Cutting)
Laporan Tahunan
Customer Satisfaction Survey
Customer Satisfaction Survey Result
Laporan Kajian Kepuasan Pelanggan
Integrity Information
Cari
fas fa-search
Laman Utama
Pengumuman
Filters
Penapis Tajuk
Papar #
5
10
15
20
25
30
50
100
Semua
Filter
Tajuk
Dikunjungi
KENYATAAN PIHAK BERKUASA PERANTI PERUBATAN (MDA) DISINFECTANT BODY SPRAY TIDAK TERTAKLUK DI BAWAH KAWALAN AKTA PERANTI PERUBATAN 2012 (AKTA 737)
Dikunjungi: 6221
Announcement for establishments on the requirements for COVID-19 self-test kits
Dikunjungi: 18589
COUNTER OPERATION
Dikunjungi: 8539
NOTIS PEMBATALAN SEBUT HARGA
Dikunjungi: 9377
ONLINE TRAINING BY THE AUTHORITY GOOD DISTRIBUTION PRACTICE FOR MEDICAL DEVICES (GDPMD)
Dikunjungi: 21158
Announcement on Enforcement of Payment for all Subsequent Notification Clinical Research Use in MeDC@St 2.0+.
Dikunjungi: 21347
PENGUMUMAN PENGUMPULAN MAKLUMAT PERIBADI BAGI PEMBELIAN KIT UJIAN KENDIRI COVID-19
Dikunjungi: 9255
PUBLIC COMMENT DRAFT MEDICAL DEVICE GUIDANCE DOCUMENT PERSONAL PROTECTIVE EQUIPMENT (PPE)-REQUIREMENTS
Dikunjungi: 7944
PENGUATKUASAAN TERMA PEMBAYARAN INVOICE BAGI SEMUA BAYARAN FI DALAM SISTEM MEDC@ST 2.0+ / ENFORCEMENT ON PAYMENT ADVICE TERM FOR ALL PAYMENT FEES IN MEDC@ST 2.0+
Dikunjungi: 8014
OFFICIAL ANNOUNCEMENT: SEMINAR BY THE AUTHORITY 2022 - REGULATORY UPDATES AND FACILITATION TOWARDS ADDRESSING THE CHALLENGES OF THE COVID-19 PANDEMIC - 31 MARCH 2022
Dikunjungi: 13936
20
21
22
23
24
25
26
27
28
29
Halaman 25 dari 41
Utama
Pengenalan
Latar Belakang
Visi, Misi & Nilai Teras
Objektif
Carta Organisasi
Kod Etika dan Tatakelakuan
Board of Directors
Top Management Team of MDA
Malaysian Leadership
Former CEO of MDA
Bahagian
Pejabat Ketua Eksekutif
Unit Komunikasi Korporat
Unit Undang-undang
Unit Integriti
Secretarial Unit
Bahagian Pendaftaran, Pelesenan Dan Penguatkuasaan
Post Market & Enforcement Division
Policy & Strategic Planning Division
International and Industry Affairs Division
Unit Pengurusan Dan Perkhidmatan
Soalan Lazim
Single License Policy Implementation
Pendaftaran, Pelesenan & Penguatkuasaan
Labelling of Medical Devices
Technical Evaluation
Hubungi
Borang Aduan Pelanggan
Direktori Kakitangan
Dokumen
Perundangan
Surat Pekeliling
Dokumen Panduan
Garis panduan
Standard
General Directions
Strategic Plan
Persembahan Slide
Infographic
Organizational Anti Corruption Plan (OACP) MDA 2022 - 2026
Buletin MDA
Press Release
Media Coverage (Newspaper Cutting)
Laporan Tahunan
Customer Satisfaction Survey
Customer Satisfaction Survey Result
Laporan Kajian Kepuasan Pelanggan
Integrity Information
×